Mikkel Bring Christensen

Research output

Research output per year 2013 2018 2019

• 29 Journal article
• 6 Review
• 3 Conference abstract in journal
• 1 Comment/debate

Research output per year

Research output per year

Search results

• 2019

  Effect of a medicines management model on medication-related readmissions in older patients admitted to a medical acute admission unit-A randomized controlled trial

  Graabaek, T., Hedegaard, U., Christensen, M. B., Clemmensen, M. H., Knudsen, T. & Aagaard, L., 1 Feb 2019, In: Journal of Evaluation in Clinical Practice. 25, 1, p. 88-96 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • medication 100%
  • medicine 84%
  • Pharmacists 82%
  • Randomized Controlled Trials 78%
  • pharmacist 59%
  9 Citations (Scopus)

• Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

  Bergmann, N. C., Lund, A., Gasbjerg, L. S., Meessen, E. C. E., Andersen, M. M., Bergmann, S., Hartmann, B., Holst, J. J., Jessen, L., Christensen, M. B., Vilsbøll, T. & Knop, F. K., 1 Apr 2019, In: Diabetologia. 62, 4, p. 665-675 11 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Appetite 88%
  • Energy Intake 85%
  • Cross-Over Studies 77%
  • Energy Metabolism 77%
  32 Citations (Scopus)

• Hemodynamic Effects of Intravenous, High-Dose Lipid Emulsion With and Without Metoprolol Infusion in Healthy Volunteers: A Randomized Clinical Trial

  Petersen, K. M., Bøgevig, S., Petersen, T. S., Jensen, T. B., Dalhoff, K. P., Henriksen, T., Poulsen, H. E. & Christensen, M. B., Apr 2019, In: Clinical Pharmacology and Therapeutics. p. 1009-1017

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Intravenous Fat Emulsions 100%
  • Metoprolol 78%
  • Emulsions 68%
  • Hemodynamics 46%
  • Randomized Controlled Trials 42%

• Long term treatment with stimulant laxatives: clinical evidence for effectiveness and safety?

  Noergaard, M., Traerup Andersen, J., Jimenez-Solem, E. & Bring Christensen, M., 2 Jan 2019, In: Scandinavian Journal of Gastroenterology. 54, 1, p. 27-34

  Research output: Contribution to journal › Review › peer-review

  • Bisacodyl 100%
  • picosulfate sodium 84%
  • Laxatives 76%
  • Safety 35%
  • Constipation 24%
  4 Citations (Scopus)

• Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes

  Bergmann, N. C., Lund, A., Gasbjerg, L. S., Jørgensen, N. R., Jessen, L., Hartmann, B., Holst, J. J., Christensen, M. B., Vilsbøll, T. & Knop, F. K., 21 Mar 2019, In: The Journal of clinical endocrinology and metabolism. 104, 7, p. 2953–2960

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Insulinotropic 100%
  • Glucagon-Like Peptide 1 94%
  • Polypeptide 49%
  • Pharmacological Metabolism 46%
  • Peptides 38%
  17 Citations (Scopus)

• Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

  Gasbjerg, L. S., Helsted, M. M., Hartmann, B., Jensen, M. H., Gabe, M. B. N., Sparre-Ulrich, A. H., Veedfald, S., Stensen, S., Lanng, A. R., Bergmann, N. C., Christensen, M. B., Vilsbøll, T., Holst, J. J., Rosenkilde, M. M. & Knop, F. K., 2019, In: Diabetes. 68, 3, p. 906-917

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Peptides 54%
  • Glucose 53%
  • exendin (9-39) 33%
  • Insulin Secretion 13%
  46 Citations (Scopus)

• The effects of dual GLP-1/GIP receptor agonism on glucagon secretion: a review

  Mathiesen, D. S., Bagger, J. I., Bergmann, N. C., Lund, A., Christensen, M. B., Vilsbøll, T. & Knop, F. K., 2019, In: International Journal of Molecular Sciences. 20, 17, 18 p., 4092.

  Research output: Contribution to journal › Review › peer-review

  • gastric inhibitory polypeptide receptor 100%
  • Insulinotropic 99%
  • Polypeptides 94%
  • Glucagon-Like Peptide 1 94%
  • secretions 82%
  12 Citations (Scopus)
• 2018

  A Systematic Review on Insulin Overdose Cases: Clinical Course, Complications and Treatment Options

  Johansen, N. J. & Christensen, M. B., Jun 2018, In: Basic & Clinical Pharmacology & Toxicology. 122, 6, p. 650-659 10 p.

  Research output: Contribution to journal › Review › peer-review

  • Insulin Derivative 100%
  • Systematic Reviews 72%
  • Insulin 66%
  • Glucose 60%
  • Electrolytes 27%
  5 Citations (Scopus)

• Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

  Demant, M., Bagger, J. I., Suppli, M. P., Lund, A., Gyldenløve, M., Hansen, K. B., Hare, K. J., Christensen, M., Sonne, D. P., Holst, J. J., Vilsbøll, T. & Knop, F. K., Dec 2018, In: Metabolic Syndrome and Related Disorders. 16, 10, p. 530-536 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Fasting 100%
  • Type 2 Diabetes Mellitus 93%
  • Glucagon 55%
  • Hemoglobins 35%
  • Waist-Hip Ratio 31%
  5 Citations (Scopus)

• Effects of high-dose, intravenous lipid emulsion on laboratory tests in humans: a randomized, placebo-controlled, double-blind, clinical crossover trial

  Petersen, K. M., Jørgensen, N. R., Bøgevig, S., Petersen, T. S., Jensen, T. B., Dalhoff, K. P. & Christensen, M. B., 1 Dec 2018, In: Clinical Chemistry and Laboratory Medicine. 56, 12, p. 2047-2057 11 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Intravenous Fat Emulsion 100%
  • Intravenous Fat Emulsions 83%
  • Cross-Over Studies 48%
  • Placebos 36%
  • Clinical Trials 34%
  1 Citation (Scopus)

• General Practitioners' Barriers Toward Medication Reviews in Polymedicated Multimorbid Patients: How can a Focus on the Pharmacotherapy in an Outpatient Clinic Support GPs?

  Laursen, J., Kornholt, J., Betzer, C., Petersen, T. S. & Christensen, M. B., 2018, In: Health Services Research and Managerial Epidemiology. 5, p. 1-7 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • outpatient clinic 100%
  • general practitioner 80%
  • Ambulatory Care Facilities 71%
  • General Practitioners 67%
  • Polypharmacy 63%
  4 Downloads (Pure)

• GIP(3-30)NH₂ is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study

  Gasbjerg, L. S., Christensen, M. B., Hartmann, B., Lanng, A. R., Sparre-Ulrich, A. H., Gabe, M. B. N., Dela, F., Vilsbøll, T., Holst, J. J., Rosenkilde, M. M. & Knop, F. K., 1 Feb 2018, In: Diabetologia. 61, 2, p. 413-423

  Research output: Contribution to journal › Journal article › Research › peer-review

  • gastric inhibitory polypeptide receptor 100%
  • Cross-Over Studies 54%
  • Placebos 41%
  • Peptides 38%
  • Glucose 37%
  45 Citations (Scopus)

• Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia

  Christensen, M. B., Lund, A., Calanna, S., Jørgensen, N. R., Holst, J. J., Vilsbøll, T. & Knop, F. K., 1 Jan 2018, In: The Journal of clinical endocrinology and metabolism. 103, 1, p. 288-294

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Insulinotropic 100%
  • Insulin Derivative 61%
  • Bone Resorption 60%
  • Polypeptide 49%
  • Parathyroid Hormone 43%
  39 Citations (Scopus)

• Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents

  Gasbjerg, L. S., Gabe, M. B. N., Hartmann, B., Christensen, M. B., Knop, F. K., Holst, J. J. & Rosenkilde, M. M., Feb 2018, In: Peptides. 100, p. 173-181

  Research output: Contribution to journal › Journal article › Research › peer-review

  • gastric inhibitory polypeptide receptor 100%
  • Insulinotropic 99%
  • Antidiabetic Agent 73%
  • Agent Interacting With Transmitter, Hormone or Drug Receptor 66%
  • Polypeptide 49%
  37 Citations (Scopus)

• Hemodynamic Effects of Glucagon: A Literature Review

  Petersen, K. M., Bogevig, S., Holst, J. J., Knop, F. K. & Christensen, M. B., 1 May 2018, In: Journal of Clinical Endocrinology & Metabolism. 103, 5, p. 1804-1812

  Research output: Contribution to journal › Review › peer-review

  • Hemodynamic 100%
  • Glucagon 92%
  • Hemodynamics 50%
  • Glucagon Receptors 9%
  • Heart Rate 9%
  12 Citations (Scopus)

• Important Aspects of Pharmacist-led Medication Reviews in an Acute Medical Ward

  Bülow, C., Faerch, K. U., Armandi, H., Jensen, B. N., Sonne, J., Christensen, H. R. & Christensen, M. B., 1 Feb 2018, In: Basic & Clinical Pharmacology & Toxicology. 122, 2, p. 253-261

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Pharmacists 100%
  • Communication 61%
  • Drug 53%
  • Pharmaceutical Preparations 41%
  • Dose 25%
  3 Citations (Scopus)

• Mono- and co-activation of the GIP and GLP-1 receptors inhibits bone resorption

  Bergmann, N. C., Lund, A., Heimburger, S. M., Gasbjerg, L. S., Jorgensen, N. R., Jessen, L., Hartmann, B., Holst, J. J., Christensen, M. B., Vilsboll, T. & Knop, F. K., 2018, In: Diabetologia. 61, S.1, p. S348-S348 717.

  Research output: Contribution to journal › Conference abstract in journal › Research

• Outcomes following calcium channel blocker exposures reported to a poison information center

  Christensen, M. B., Petersen, K. M., Bøgevig, S., Al-Gibouri, S., Jimenez-Solem, E., Dalhoff, K. P., Petersen, T. S. & Andersen, J. T., 27 Nov 2018, In: B M C Clinical Pharmacology. 19, 1, p. 1-8 8 p., 78.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Information Centers 100%
  • Calcium Channel Blockers 82%
  • Poisons 56%
  • Medication Errors 27%
  • Verapamil 23%
  2 Citations (Scopus)

  19 Downloads (Pure)

• Overdoses with Aripiprazole: Signs, Symptoms and Outcome in 239 Exposures Reported to the Danish Poison Information Centre

  Christensen, A. P., Boegevig, S., Christensen, M. B., Petersen, K. M., Dalhoff, K. P. & Petersen, T. S., 1 Feb 2018, In: Basic & Clinical Pharmacology & Toxicology. 122, 2, p. 293-298 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Aripiprazole 100%
  • Information Centers 79%
  • Poison 70%
  • Signs and Symptoms 52%
  • Poisons 45%
  2 Citations (Scopus)

• Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark

  Schiøtz, M. L., Frølich, A., Jensen, A. K., Reuther, L., Perrild, H., Petersen, T. S., Kornholt, J. & Christensen, M. B., Dec 2018, In: Pharmacology Research & Perspectives. 6, 6, 6 p., e00431.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Deprescriptions 100%
  • Polypharmacy 73%
  • Denmark 64%
  • Health Personnel 20%
  • Multimorbidity 16%
  9 Citations (Scopus)

  45 Downloads (Pure)

• Postprandial effects of individual and combined GIP and GLP-1 receptor antagonism in healthy subjects

  Gasbjerg, L. S., Helsted, M. M., Sparre-Ulrich, A. H., Lanng, A. R., Stensen, S., Jakobsen, M. H., Hartmann, B., Christensen, M. B., Holst, J. J., Vilsboll, T., Rosenkilde, M. M. & Knop, F. K., 2018, In: Diabetologia. 61, S1, p. S246-S246 503.

  Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

• Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes

  Nerild, H. H., Christensen, M. B., Knop, F. K. & Brønden, A., 2018, In: Expert Opinion on Drug Discovery. 13, 12, p. 1161-1167 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Colesevelam 100%
  • Colesevelam Hydrochloride 76%
  • Type 2 Diabetes Mellitus 32%
  • LDL Lipoproteins 14%
  • Glucose 13%
  5 Citations (Scopus)

• Response to Letter to the Editor: "Hemodynamic Effects of Glucagon: A Literature Review"

  Petersen, K. M., Bøgevig, S., Holst, J. J., Knop, F. K. & Christensen, M. B., 2018, In: The Journal of clinical endocrinology and metabolism. 103, 12, p. 4480-4481 2 p.

  Research output: Contribution to journal › Comment/debate › Research

  1 Citation (Scopus)

• The role of the incretins in the postprandial bone remodelling

  Helsted, M. M., Gasbjerg, L. S., Lanng, A. R., Stensen, S., Hartmann, B., Christensen, M. B., Holst, J. J., Vilsboll, T., Rosenkilde, M. M. & Knop, F. K., 2018, In: Diabetologia. 61, S1, p. S221-S221 449.

  Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

• Ventrikelaspiration er meget sjældent indiceret ved forgiftninger

  Translated title of the contribution: Indications for orogastric emptying in poisonings are rarely presentBøgevig, S., Christensen, M. B., Petersen, J. A., Dalhoff, K. P., Petersen, T. S., Palmqvist, D. F. & Groth Høgberg, L. C., 2018, In: Ugeskrift for Laeger. 180, 49, 4 p., V04180252.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Poisoning 100%
  • Information Centers 43%
  • Decontamination 41%
  • Gastric Emptying 37%
  • Therapeutic Irrigation 37%
• 2017

  An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions

  Vinther, S., Klarskov, P., Borgeskov, H., Darso, P., Christophersen, A. K., Borck, B., Christensen, C., Hansen, M. V., Halladin, N. M. L., Christensen, M. B., Harboe, K. M., Lund, M. & Jimenez-Solem, E., Jan 2017, In: Danish Medical Journal. 64, 1, 5 p., A5315.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Drug-Related Side Effects and Adverse Reactions 100%
  • Psychological Signal Detection 10%
  • Rivaroxaban 10%
  • Fatal Outcome 9%
  • Otolaryngology 8%
  6 Citations (Scopus)

• Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide

  Brønden, A., Knop, F. K. & Christensen, M. B., 1 Jul 2017, In: Clinical Pharmacokinetics. 56, 7, p. 719-731

  Research output: Contribution to journal › Review › peer-review

  • rGLP-1 protein 100%
  • Pharmacokinetics 41%
  • Glucagon-Like Peptide-1 Receptor 19%
  • Placebos 13%
  • Type 2 Diabetes Mellitus 7%
  9 Citations (Scopus)

• Quality of care for people with multimorbidity: a case series

  Schiøtz, M. L., Høst, D., Christensen, M. B., Domínguez, H., Hamid, Y., Almind, M., Sørensen, K. L., Saxild, T., Holm, R. H. & Frølich, A., 18 Nov 2017, In: BMC Health Services Research. 17, 9 p., 745.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Multimorbidity 100%
  • Quality of care 80%
  • Quality of Health Care 64%
  • medication 31%
  • General Practice 31%
  6 Citations (Scopus)

  88 Downloads (Pure)
• 2016

  Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

  Storgaard, H., Gluud, L. L., Bennett, C., Grøndahl, M. F., Christensen, M. B., Knop, F. K. & Vilsbøll, T., Nov 2016, In: PLOS ONE. 11, 11, 23 p., e0166125.

  Research output: Contribution to journal › Review › peer-review

  • sodium glucose cotransporter-2 inhibitors 100%
  • Sodium-Glucose Transporter 2 Inhibitors 66%
  • Sodium 65%
  • Symporters 63%
  • Diabetes 62%
  111 Citations (Scopus)

• Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans

  Christensen, M. B., Apr 2016, In: Danish Medical Journal. 63, 4, p. 1-19 19 p., B5230.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon 100%
  • Insulin Secretion 95%
  • Peptides 61%
  • Glucose 60%
  • Blood Glucose 28%
  11 Citations (Scopus)

• Higher Endogenous Glucose Production during OGTT vs Isoglycemic Intravenous Glucose Infusion

  Lund, A., Bagger, J. I., Christensen, M. B., Grøndahl, M., van Hall, G., Holst, J. J., Lauritsen, T. V. & Knop, F. K., Nov 2016, In: The Journal of Clinical Endocrinology & Metabolism. 101, 11, p. 4377-4384

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucose Tolerance Test 100%
  • Intravenous Infusions 95%
  • Glucose 72%
  • Glucagon 38%
  • Type 2 Diabetes Mellitus 13%
  5 Citations (Scopus)
• 2015

  Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes

  Christensen, M., Calanna, S., Sparre-Ulrich, A. H., Kristensen, P. L., Rosenkilde, M. M., Faber, J., Purrello, F., van Hall, G., Holst, J. J., Vilsbøll, T. & Knop, F. K., 1 Jan 2015, In: Diabetes. 64, 1, p. 72-78 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon 100%
  • Hypoglycemia 92%
  • Type 1 Diabetes Mellitus 85%
  • Peptides 61%
  • Glucose 60%
  39 Citations (Scopus)

• Laktoseholdige lægemidler kan som hovedregel indtages af personer med laktoseintolerans

  Translated title of the contribution: Pharmaceutical drugs containing lactose can as a rule be used by persons with lactose intoleranceVinther, S., Rumessen, J. J. & Christensen, M., 9 Mar 2015, In: Ugeskrift for Laeger. 177, 24, p. 2-5 4 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Lactose Intolerance 100%
  • Lactose 80%
  • Pharmaceutical Preparations 28%
  • Excipients 20%
  • Treatment Adherence and Compliance 19%
  1 Citation (Scopus)
• 2014

  Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease

  Idorn, T., Knop, F. K., Jørgensen, M. B., Christensen, M., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., 8 Apr 2014, In: The Journal of clinical endocrinology and metabolism. 99, 7, p. 2457-66 10 p., jc20133809.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Insulinotropic 100%
  • Glucagon-Like Peptide 1 94%
  • Chronic Kidney Failure 52%
  • Polypeptide 49%
  • Peptides 38%
  20 Citations (Scopus)

  58 Downloads (Pure)

• Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes

  Christensen, M. B., Calanna, S., Holst, J. J., Vilsbøll, T. & Knop, F. K., Mar 2014, In: The Journal of clinical endocrinology and metabolism. 99, 3, p. E418-26 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Insulinotropic 100%
  • Blood Glucose 49%
  • Polypeptide 49%
  • Type 2 Diabetes Mellitus 45%
  • Glucose 44%
  52 Citations (Scopus)

• Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans

  Nissen, A., Christensen, M., Knop, F. K., Vilsbøll, T., Holst, J. J. & Hartmann, B., 1 Nov 2014, In: The Journal of clinical endocrinology and metabolism. 99, 11, p. E2325-9 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Insulinotropic 100%
  • Bone Resorption 60%
  • Polypeptide 49%
  • Peptides 38%
  • Glucose 37%
  74 Citations (Scopus)

• The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

  Storgaard, H., Gluud, L. L., Christensen, M., Knop, F. K. & Vilsbøll, T., 2014, In: B M J Open. 4, 8, p. 1-5 5 p., e005378.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Sodium-Glucose Transporter 2 Inhibitors 100%
  • Symporters 94%
  • Type 2 Diabetes Mellitus 51%
  • Meta-Analysis 51%
  • Systematic Reviews 50%
  5 Citations (Scopus)
• 2013

  GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

  Jespersen, M. J., Knop, F. K. & Christensen, M., Jan 2013, In: Expert Opinion on Drug Metabolism & Toxicology. 9, 1, p. 17-29 13 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide-1 Receptor Agonist 100%
  • Glucagon-Like Peptide-1 Receptor 66%
  • Glucagon-Like Peptide 1 59%
  • Exenatide 55%
  • Toxicology 49%
  37 Citations (Scopus)

• Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies

  Calanna, S., Christensen, M., Holst, J. J., Laferrère, B., Gluud, L. L., Vilsbøll, T. & Knop, F. K., Oct 2013, In: Diabetes Care. 36, 10, p. 3346-52 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Type 2 Diabetes Mellitus 100%
  • Meta-Analysis 99%
  • Systematic Reviews 98%
  • Clinical Studies 92%
  • Peptides 84%
  91 Citations (Scopus)